These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2550134)

  • 41. [Hyperimmunoglobulin treatment in CMV infections following heart transplantation].
    Cremer J; Schäfers HJ; Wahlers T; Fieguth HG; Milbradt H; Flik J; Haverich A
    Dtsch Med Wochenschr; 1988 Jan; 113(1):18-20. PubMed ID: 2826099
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The use of intravenous immune globulin in organ transplantation.
    Platt D; Maderazo E; Chime-Udeh E
    Conn Med; 1991 Aug; 55(8):468-70. PubMed ID: 1657517
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytomegalovirus infection after kidney transplantation using cyclosporin A and low-dose prednisolone immunosuppression.
    Mayer G; Watschinger B; Pohanka E; Graf H; Popow T; Ulrich W; Kovarik J
    Nephrol Dial Transplant; 1988; 3(4):464-8. PubMed ID: 2845305
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cytomegalovirus hyperimmunoglobulin prophylaxis following kidney transplantation. Results of a prospective randomized study].
    Grundmann R; Wienand P; Runde A; Baldamus CA; Arns W; Burkhardt U
    Dtsch Med Wochenschr; 1987 May; 112(21):827-31. PubMed ID: 3034541
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prophylactic use of anti-CMV immunoglobulins in heart transplant recipients: a study on its safety.
    Metselaar HJ; Velzing J; Rothbarth PH; Balk AH; Mochtar B; Weimar W
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2504-5. PubMed ID: 2539677
    [No Abstract]   [Full Text] [Related]  

  • 46. [Monoclonal immunoglobulins, cytomegalovirus infection and malignant observations blood diseases].
    Danon F; Bussel A; Perol Y
    Ann Immunol (Paris); 1977; 128(1-2):83-5. PubMed ID: 192134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. On the relation between cytomegalovirus infection and rejection after heart transplantation.
    Weimar W; Balk AH; Metselaar HJ; Mochtar B; Rothbarth PH
    Transplantation; 1991 Jul; 52(1):162-4. PubMed ID: 1650044
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical course of cytomegalovirus infection in adults].
    Heni N; Heissmeyer HH; Baumgartner M
    Dtsch Med Wochenschr; 1986 Mar; 111(13):499-503. PubMed ID: 3007064
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effectiveness of Prophylactic Human Cytomegalovirus Hyperimmunoglobulin in Preventing Cytomegalovirus Infection following Transplantation: A Systematic Review and Meta-Analysis.
    Barten MJ; Baldanti F; Staus A; Hüber CM; Glynou K; Zuckermann A
    Life (Basel); 2022 Mar; 12(3):. PubMed ID: 35330112
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of patients at risk of symptomatic cytomegalovirus infection after open-heart surgery.
    Reikvam A; Orstavik I; Endresen K; Bae E
    Scand J Thorac Cardiovasc Surg; 1985; 19(2):173-6. PubMed ID: 2996127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Passive immunization to prevent cytomegalovirus disease after kidney and heart transplantation.
    Weimar W; Metselaar HJ; Balk AH; Mochtar B; Rothbarth PH; Jeekel J
    Transplant Proc; 1990 Feb; 22(1):229-32. PubMed ID: 2155488
    [No Abstract]   [Full Text] [Related]  

  • 52. Prophylactic application of an anti-cytomegalovirus hyperimmunoglobulin in allogeneic bone marrow transplant recipients.
    Reusser P; Osterwalder B; Gratwohl A; Gratama J; The T; Speck B
    Haematol Blood Transfus; 1987; 30():541-4. PubMed ID: 3040548
    [No Abstract]   [Full Text] [Related]  

  • 53. Lack of association between cytomegalovirus infection of heart and rejection-like inflammation.
    Stovin PG; Wreghitt TG; English TA; Wallwork J
    J Clin Pathol; 1989 Jan; 42(1):81-3. PubMed ID: 2537855
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Infections following heart transplantation; experiences in 40 patients].
    Balk AH; Sluiters JF; Degener JE; Rothbarth PH; Metselaar HJ; Mochtar B
    Ned Tijdschr Geneeskd; 1988 Dec; 132(49):2237-41. PubMed ID: 2849723
    [No Abstract]   [Full Text] [Related]  

  • 55. The first clinical pig heart transplant: Was IVIg or pig cytomegalovirus detrimental to the outcome?
    Cooper DKC; Yamamoto T; Hara H; Pierson RN
    Xenotransplantation; 2022 Jul; 29(4):e12771. PubMed ID: 35942912
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Is the administration of immunoglobulins following bone marrow transplantation indicated?].
    Klingemann HG
    Klin Wochenschr; 1987 Sep; 65(18):845-51. PubMed ID: 2822997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The value of isolation procedures for cytomegalovirus infections in children with leukemia.
    Cox F; Hughes WT
    Cancer; 1975 Sep; 36(3):1158-61. PubMed ID: 171054
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Infections in solid-organ transplant recipients.
    Patel R; Paya CV
    Clin Microbiol Rev; 1997 Jan; 10(1):86-124. PubMed ID: 8993860
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prophylactic use of hyperimmunoglobulin for cytomegalovirus infection in heart transplantation.
    Havel MP; Laczkovics AM; Wolner E; Kurz RW; Popow-Kraupp T
    Clin Ther; 1989; 11(4):472-8. PubMed ID: 2550134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
    Falagas ME; Snydman DR; Ruthazer R; Griffith J; Werner BG; Freeman R; Rohrer R
    Clin Transplant; 1997 Oct; 11(5 Pt 1):432-7. PubMed ID: 9361936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.